Margaret A. Gates, Sc.D.

SUNY Assistant Professor of Epidemiology
Department of Epidemiology and Biostatistics

Department of Epidemiology & Biostatistics
Dr. GatesSchool of Public Health
One University Place, Room 133
Rensselaer, NY 12144-3456

Phone:  518-402-0397

Sc.D. Epidemiology, Harvard School of Public Health, 2007
Postdoctoral Research Fellow in Epidemiology, Harvard School of Public Health, 2007-2010

Research Interests:
Cancer epidemiology and prevention, modifiable risk factors for breast and ovarian cancer, cancer disparities, cancer survival

EPI 601 General Topics in Epidemiologic Methods
EPI 612 Quantitative Methods in Epidemiology

Selected Publications and Presentations

Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer 2012;130:2129-37.

Gates MA, Araujo AB, Hall SA, Wittert GA, McKinlay JB. Non-steroidal anti-inflammatory drug use and levels of oestrogens and androgens in men. Clin Endocrinol (Oxf) 2012; 76:272-80.

Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011;128:482-6.

Gates MA, Rosner BA, Hecht JL, Tworoger SS. Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol 2010;171:45-53.

Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE. Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19:1033-41.

Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 2009;69:1885-91.

Gates MA, Tworoger SS, Terry KL, De Vivo I, Hunter DJ, Hankinson SE, Cramer DW. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. Int J Cancer 2009;124:729-33.

Gates MA, Vitonis AF, Tworoger SS, Rosner B, Titus-Ernstoff L, Hankinson SE, Cramer DW. Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer 2009;124:1918-25.

Gates MA, Tworoger SS, Terry KL, Titus-Ernstoff L, Rosner B, De Vivo I, Cramer DW, Hankinson SE. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2436-44.

Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 2007;121:2225-32.